Market Expansion Leverage QbD Group’s Gateway to Europe and multi-country presence to target non-EU biotech and medtech innovators seeking European market entry, regulatory support, and lifecycle management.

Acquisition Insight QbD Group has actively expanded through acquisitions (Azierta, Turnstone Communications, BioVox, EUDRAC, Michor Consulting), signaling opportunities to offer integrated consulting services to clients undergoing consolidation or needing broader regulatory, communications, and pharmacovigilance capabilities.

Regulatory & Quality Edge With deep regulatory, clinical, and quality expertise, position as a preferred partner for life sciences firms aiming to accelerate development timelines, ensure compliance, and secure faster market access across Europe.

Full Lifecycle Fit Target mid-sized Biotech and MedTech firms seeking end-to-end support from idea validation to submission and post-market lifecycle activities, highlighting QbD as a one-stop solution to reduce risk and speed up time-to-patient.

Digital & Communication Services Capitalize on QbD Group’s strengthened science communication and marketing capabilities from recent acquisitions to cross-sell services to clients needing regulatory updates, clinical communications, and market access messaging.